The impact of long-term targeted therapy with omalizumab (more than 2 years) on the asthma control according to the registry of children with uncontrolled severe persistent asthma (Russian experience)

被引：0
|
作者：
Namazova-Baranova, L. [1 ]
Vishneva, E. [1 ]
Dobrynina, E. [1 ]
Alekseeva, A. [1 ]
Levina, J. [1 ]
Efendieva, K. [1 ]
Kalugina, V [1 ]
Voznesenskaya, N. [1 ]
Selimzyanova, L. [1 ]
Promyslova, E. [1 ]
机构：
[1] Sci Ctr Childrens Hlth, Moscow, Russia
来源：
ALLERGY | 2017年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0976
引用
收藏
页码：559 / 560
页数：2
相关论文
共 50 条
  • [41] Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis (vol 5, 8191, 2015)
    Lai, Tianwen
    Wang, Shaobin
    Xu, Zhiwei
    Zhang, Chao
    Zhao, Yun
    Hu, Yue
    Cao, Chao
    Ying, Songmin
    Chen, Zhihua
    Li, Wen
    Wu, Bin
    Shen, Huahao
    SCIENTIFIC REPORTS, 2015, 5
  • [42] LONG-TERM CONTROL OF SEVERE BRONCHIAL ASTHMA WITH ORAL CORTISONE .2. REPORT
    BROCKBANK, W
    SAVIDGE, RS
    BREBNER, H
    LANCET, 1957, 2 (OCT5): : 666 - 670
  • [43] IMPACT OF ENVIRONMENTAL EXPOSURES (SECOND HAND SMOKING AND/OR PETS) ON LONG-TERM ASTHMA CONTROL IN CHILDREN
    Sheikh, Shahid
    Pitts, Judy
    Salvator, Ann
    Nemastil, Christopher
    Pinto, Swaroop
    CHEST, 2018, 154 (04) : 738A - 738A
  • [44] Dupilumab Improved Long-term Lung Function in Children Aged 6 to 11 Years With Moderate-to-Severe Asthma: Liberty Asthma Excursion
    Bacharier, L. B.
    Maspero, J. F.
    Katelaris, C. H.
    Fiocchi, A. G.
    Gagnon, R.
    de Mir, I.
    Guilbert, T. W.
    Jackson, D. J.
    Li, N.
    Akinlade, B.
    Laws, E.
    Mannent, L. P.
    Maloney, J.
    Tawo, K.
    Khokhar, F. A.
    Hardin, M.
    Abdulai, R. M.
    Lederer, D. J.
    Robinson, L. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [45] Omalizumab Treatment for Atopic Severe Persistant Asthma: A Single-Center, Long-Term, Real-Life Experience with 38 Patients
    Turk, Murat
    Bahcecioglu, Sakine Nazik
    Tutar, Nuri
    Oymak, Fatma Sema
    Gulmez, Inci
    Yilmaz, Insu
    TURKISH THORACIC JOURNAL, 2018, 19 (04) : 187 - 192
  • [46] The Long-Term Efficacy and Safety of Mepolizumab in Children from 6 to 11 Years of Age with Severe Eosinophilic Asthma
    Steinfeld, J.
    Gupta, A.
    Ikeda, M.
    Geng, B.
    Azmi, J.
    Price, R.
    Bradford, E.
    Yancey, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [47] Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older
    Williams, B
    Noonan, G
    Reiss, TF
    Knorr, B
    Guerra, J
    White, R
    Matz, J
    CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (06): : 845 - 854
  • [48] The effect of the COVID-19 pandemic on long-term treatment compliance and disease control in children with persistent asthma
    Ozcan, Sevilay Ozerden
    Terece, Sinem Polat
    Yalcin, Gamze
    Karagol, Hacer Ilbilge Ertoy
    Bakirtas, Arzu
    TURKISH JOURNAL OF PEDIATRICS, 2023, 65 (05) : 739 - 747
  • [49] Long-term effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Real-life data from 3 UK centres
    Britton, Mark
    Howes, Timothy
    Saralaya, Dinesh
    Hepburn, Deborah
    Nordstrom, Monica
    Welham, Kate
    Regan, Karen
    Kasujee, Ismail
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [50] Long-Term Efficacy of Dupilumab in Quadrants of Elevated- vs Low- Type 2 Biomarker Patients With Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA TRAVERSE
    Wechsler, Michael
    Pavord, Ian
    Papi, Alberto
    Chapman, Kenneth
    Mao, Xuezhou
    Ortiz, Benjamin
    Djandji, Michel
    Jacob-Nara, Juby
    Rowe, Paul
    Deniz, Yamo
    Laws, Elizabeth
    Akinlade, Bolanle
    Amin, Nikhil
    Lederer, David
    Hardin, Megan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB190 - AB190
12345